7-151876511-A-G

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4

The NM_016203.4(PRKAG2):​c.110T>C​(p.Ile37Thr) variant causes a missense change. The variant allele was found at a frequency of 0.000000693 in 1,443,786 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I37M) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 6.9e-7 ( 0 hom. )

Consequence

PRKAG2
NM_016203.4 missense

Scores

2
11
7

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 4.40

Publications

0 publications found
Variant links:
Genes affected
PRKAG2 (HGNC:9386): (protein kinase AMP-activated non-catalytic subunit gamma 2) AMP-activated protein kinase (AMPK) is a heterotrimeric protein composed of a catalytic alpha subunit, a noncatalytic beta subunit, and a noncatalytic regulatory gamma subunit. Various forms of each of these subunits exist, encoded by different genes. AMPK is an important energy-sensing enzyme that monitors cellular energy status and functions by inactivating key enzymes involved in regulating de novo biosynthesis of fatty acid and cholesterol. This gene is a member of the AMPK gamma subunit family. Mutations in this gene have been associated with Wolff-Parkinson-White syndrome, familial hypertrophic cardiomyopathy, and glycogen storage disease of the heart. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jan 2015]
PRKAG2-AS1 (HGNC:40468): (PRKAG2 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.3390531).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PRKAG2NM_016203.4 linkc.110T>C p.Ile37Thr missense_variant Exon 1 of 16 ENST00000287878.9 NP_057287.2 Q9UGJ0-1A0A090N8Q6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PRKAG2ENST00000287878.9 linkc.110T>C p.Ile37Thr missense_variant Exon 1 of 16 1 NM_016203.4 ENSP00000287878.3 Q9UGJ0-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
6.93e-7
AC:
1
AN:
1443786
Hom.:
0
Cov.:
31
AF XY:
0.00000139
AC XY:
1
AN XY:
719092
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33062
American (AMR)
AF:
0.00
AC:
0
AN:
44458
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25708
East Asian (EAS)
AF:
0.0000258
AC:
1
AN:
38820
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86154
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
45046
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5662
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1105340
Other (OTH)
AF:
0.00
AC:
0
AN:
59536
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Cardiovascular phenotype Uncertain:1
Jun 22, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.I37T variant (also known as c.110T>C), located in coding exon 1 of the PRKAG2 gene, results from a T to C substitution at nucleotide position 110. The isoleucine at codon 37 is replaced by threonine, an amino acid with similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.77
CardioboostCm
Uncertain
0.25
BayesDel_addAF
Uncertain
0.12
D
BayesDel_noAF
Uncertain
-0.060
CADD
Uncertain
25
DANN
Uncertain
0.99
DEOGEN2
Benign
0.081
T
Eigen
Uncertain
0.19
Eigen_PC
Uncertain
0.23
FATHMM_MKL
Benign
0.73
D
LIST_S2
Benign
0.81
T
M_CAP
Uncertain
0.19
D
MetaRNN
Benign
0.34
T
MetaSVM
Uncertain
-0.034
T
MutationAssessor
Benign
1.4
L
PhyloP100
4.4
PrimateAI
Pathogenic
0.87
D
PROVEAN
Benign
-0.34
N
REVEL
Uncertain
0.52
Sift
Uncertain
0.015
D
Sift4G
Uncertain
0.039
D
Polyphen
0.81
P
Vest4
0.51
MutPred
0.32
Gain of phosphorylation at I37 (P = 0.0146);
MVP
0.72
MPC
1.6
ClinPred
0.93
D
GERP RS
4.0
Varity_R
0.22
gMVP
0.27
Mutation Taster
=75/25
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

hg19: chr7-151573596; API